FEDER - UNICAEN (ISTS and COMETE LABOS) - PEPSY PROJECT
Kohesio
UNIVERSITE DE CAEN NORMANDIE
Schizophrenia is a common mental illness (1%) beginning in young adults and which represents a heavy burden for patients, their loved ones, the health system, the social and medico-social system and society in general. It is considered by the WHO to be the eighth cause of disability among 15 to 44 year olds. Its cost for the health system represents 1.1% of national health expenditure and 120/000 of the gross domestic product (GDP). People suffering from schizophrenia are very sedentary and have risk factors causing excess mortality (life expectancy reduced by 10 to 15 years). In fact, these patients have, compared to the general population, higher rates of obesity, diabetes, hypercholesterolemia and cardiovascular diseases (heart attacks, arrhythmia, high blood pressure). They also have cognitive disorders (memory and learning deficits, deficits in establishing action plans) leading to social and professional disintegration. The search for therapies complementary to usual treatment (antipsychotics), acting on these risk factors and these cognitive deficits, is a real challenge. Among these therapies, Adapted Physical Activity (APA) capable of acting on these two aspects should have a considerable impact in terms of the well-being of the person, the prevention of risk factors and health costs. This project will focus on the effects of Adapted Physical Activity (APA) on the health of schizophrenia patients. It will consist of: 1- setting up an innovative teaching method (first in the field) and adapted to this audience (e-coaching or distance coaching) thanks to the expertise of the company V@SI; 2- to demonstrate the effectiveness of such therapy on the mental health (well-being, quality of life), physical health (metabolic, cardiac, cerebral) and cognitive functions (particularly memory) of patients suffering from schizophrenia, 3- to evaluate, thanks to the expertise of the company BodyCap, the impact of this therapy on the 24-hour biological rhythms (temperature, sleep/wake cycle) known to be disrupted in these patients; 4- to develop a computer interface allowing continuous and remote monitoring of heart rate during APA thanks to the expertise of the company Ob'do (essential for these patients receiving medications likely to modify their heart rate). This project will lead to the development and dissemination of this remote APA therapy at the regional and then national level for patients suffering from schizophrenia but also other disorders such as depression and addictions causing sedentary lifestyle and social isolation.
Smarter Europe / Research and innovation / Research and innovation activities in public research centres and centres of competence including networking